STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Tangible Net Worth Ratio
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€19.00 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore STARPHARMA HLDG.SP.ADR/10 equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
STARPHARMA HLDG.SP.ADR/10 Tangible Net Worth Ratio (2022–2025)
This chart shows how STARPHARMA HLDG.SP.ADR/10's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €19.00 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see PQ6A stock market capitalisation.
Annual Tangible Net Worth Ratio for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | €19.00 Million | €0.00 | €25.42 Million | ▲ +0.0 pp |
| 2024 | 100.0% | €28.12 Million | €0.00 | €36.81 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €34.81 Million | €0.00 | €52.09 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €48.39 Million | €0.00 | €66.17 Million | — |